Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts’ Top Healthcare Picks: Beyond Air (XAIR), Molina Healthcare (MOH)

Tipranks - Fri Feb 6, 10:26AM CST

Analysts fell to the sidelines weighing in on Beyond Air (XAIRResearch Report) and Molina Healthcare (MOHResearch Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks.

Claim 50% Off TipRanks Premium

Beyond Air (XAIR)

In a report issued on February 3, Marie Thibault from BTIG maintained a Hold rating on Beyond Air. The company’s shares closed last Thursday at $1.04.

According to TipRanks.com, Thibault has 0 stars on 0-5 stars ranking scale with an average return of -8.8% and a 36.5% success rate. Thibault covers the Healthcare sector, focusing on stocks such as Kestra Medical Technologies Ltd., Orchestra BioMed Holdings, and Irhythm Technologies. ;'>

Beyond Air has an analyst consensus of Moderate Buy, with a price target consensus of $5.50, representing a 404.6% upside. In a report issued on January 30, TipRanks – Google also reiterated a Hold rating on the stock with a $1.50 price target.

See the top stocks recommended by analysts >>

Molina Healthcare (MOH)

Guggenheim analyst Jason Cassorla maintained a Hold rating on Molina Healthcare on February 3. The company’s shares closed last Thursday at $179.31.

According to TipRanks.com, Cassorla is ranked 0 out of 5 stars with an average return of -4.2% and a 47.8% success rate. Cassorla covers the Healthcare sector, focusing on stocks such as Ardent Health Partners, Inc., Acadia Healthcare, and Universal Health. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Molina Healthcare with a $200.14 average price target, a 13.3% upside from current levels. In a report issued on January 27, Truist Financial also maintained a Hold rating on the stock.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.